Child–Parent Familial Hypercholesterolemia Screening in Primary Care
Reads0
Chats0
TLDR
Child-parent screening was feasible in primary care practices at routine child immunization visits and 8 persons were identified as having positive screening results for familial hypercholesterolemia and were consequently at high risk for cardiovascular disease.Abstract:
BackgroundChild–parent screening for familial hypercholesterolemia has been proposed to identify persons at high risk for inherited premature cardiovascular disease. We assessed the efficacy and feasibility of such screening in primary care practice. MethodsWe obtained capillary blood samples to measure cholesterol levels and to test for familial hypercholesterolemia mutations in 10,095 children 1 to 2 years of age during routine immunization visits. Children were considered to have positive screening results for familial hypercholesterolemia if their cholesterol level was elevated and they had either a familial hypercholesterolemia mutation or a repeat elevated cholesterol level 3 months later. A parent of each child with a positive screening result for familial hypercholesterolemia was considered to have a positive screening result for familial hypercholesterolemia if he or she had the same mutation as the child or, if no mutations were identified, had the higher cholesterol level of the two parents. Re...read more
Citations
More filters
Journal ArticleDOI
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy,Neil J. Stone,Alison L. Bailey,Craig A. Beam,Kim K. Birtcher,Roger S. Blumenthal,Lynne T. Braun,Sarah D. de Ferranti,Joseph Faiella-Tommasino,Daniel E. Forman,Ronald N. Goldberg,Paul A. Heidenreich,Mark A. Hlatky,Daniel W. Jones,Donald M. Lloyd-Jones,Nuria Lopez-Pajares,Chiadi E Ndumele,Carl E. Orringer,Carmen A. Peralta,Joseph J. Saseen,Sidney C. Smith,Laurence S. Sperling,Salim S. Virani,Joseph Yeboah +23 more
TL;DR: The next generation of scientists and decision-makers will be shaped by the experiences of those who have gone before them and will help shape the future of medicine and science.
Journal ArticleDOI
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
Amy C. Sturm,Joshua W. Knowles,Samuel S. Gidding,Zahid Ahmad,Catherine D. Ahmed,Christie M. Ballantyne,Seth J. Baum,Mafalda Bourbon,Alain Carrié,Marina Cuchel,Sarah D. de Ferranti,Joep C. Defesche,Tomáš Freiberger,Ray E. Hershberger,G. Kees Hovingh,Lala Karayan,Johannes Jacob Pieter Kastelein,Iris Kindt,Stacey R. Lane,Sarah Leigh,MacRae F. Linton,Pedro Mata,William A. Neal,Børge G. Nordestgaard,Raul D. Santos,Mariko Harada-Shiba,Eric J.G. Sijbrands,Nathan O. Stitziel,Shizuya Yamashita,Katherine Wilemon,David H. Ledbetter,Daniel J. Rader +31 more
TL;DR: The Expert Consensus Panel recommends that FH genetic testing become the standard of care for patients with definite or probable FH, as well as for their at-risk relatives, and more accurate risk stratification.
Journal ArticleDOI
Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
Pengwei Hu,Kanika I. Dharmayat,C. Stevens,Mansour T. A. Sharabiani,Rebecca Jones,Gerald F. Watts,Gerald F. Watts,Jacques Genest,Kausik K. Ray,Antonio J. Vallejo-Vaz +9 more
TL;DR: With an overall prevalence of 1:311, FH is among the commonest genetic disorders in the GP, similarly present across different regions of the world, and is more frequent among those with ASCVD.
Journal ArticleDOI
Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
Sabina Beheshti,Christian M. Madsen,Anette Varbo,Børge G. Nordestgaard,Børge G. Nordestgaard +4 more
TL;DR: FH prevalence in the general population was similar using genetic versus clinical diagnoses, and FH prevalence is 10-fold higher among those with IHD, 20-fold Higher among thoseWith premature IHD and 23-foldHigher among thosewith severe hypercholesterolemia.
Journal ArticleDOI
Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.
Leo E. Akioyamen,Jacques Genest,Shubham D. Shan,Rachel L Reel,Jordan M. Albaum,Anna Chu,Jack V. Tu +6 more
TL;DR: The authors' systematic review suggests that FH is a common disorder, affecting 1 in 250 individuals, and underscore the need for early detection and management to decrease CVD risk.
References
More filters
Journal ArticleDOI
Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.
TL;DR: The lack of clinical expression in obligate FH heterozygotes is not due to unusually "mild" mutations in the LDL-receptor gene, and other genetic or environmental factors must therefore be important in determining phenotypic expression.
Journal ArticleDOI
Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
TL;DR: An ambitious meta-analysis of 13 independent studies, including a total of 1907 people with FH and 16,221 controls, presents clear age-related differences in the ability to distinguish between affected and unaffected individuals based upon serum cholesterol measurements.
Journal ArticleDOI
Discriminative Ability of LDL-Cholesterol to Identify Patients With Familial Hypercholesterolemia A Cross-Sectional Study in 26 406 Individuals Tested for Genetic FH
TL;DR: The overlap in terms of LDL-C levels between those with molecularly proven FH and unaffected relatives is to a large extent because of the high prevalence of modestly severe LDL-receptor mutations in the Netherlands.
Journal ArticleDOI
Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
TL;DR: The results indicate that FH is more genetically diverse in Ontario than in Quebec, and are consistent with findings from investigations of the LDLR in FH conducted in other countries, in which PCR‐based, exon‐by‐exon sequencing uncovers small mutations in about half of the subjects screened.
Related Papers (5)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
Børge G. Nordestgaard,M. John Chapman,Steve E. Humphries,Henry N. Ginsberg,Luis Masana,Olivier S. Descamps,Olov Wiklund,Robert A. Hegele,Frederick J. Raal,Joep C. Defesche,Albert Wiegman,Raul D. Santos,Gerald F. Watts,Klaus G. Parhofer,G. Kees Hovingh,Petri T. Kovanen,Catherine Boileau,Maurizio Averna,Jan Borén,Eric Bruckert,Alberico L. Catapano,Jan Albert Kuivenhoven,Jan Albert Kuivenhoven,P. Pajukanta,Kausik K. Ray,Anton F. H. Stalenhoef,Erik S.G. Stroes,Marja-Riitta Taskinen,Anne Tybjærg-Hansen +28 more
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Amit Khera,Amit Khera,Hong-Hee Won,Gina M. Peloso,Gina M. Peloso,Kim Lawson,Traci M. Bartz,Xuan Deng,Elisabeth M. van Leeuwen,Pradeep Natarajan,Pradeep Natarajan,Connor A. Emdin,Alexander G. Bick,Alanna C. Morrison,Jennifer A. Brody,Namrata Gupta,Akihiro Nomura,Akihiro Nomura,Thorsten Kessler,Stefano Duga,Joshua C. Bis,Cornelia M. van Duijn,L. Adrienne Cupples,Bruce M. Psaty,Daniel J. Rader,John Danesh,Heribert Schunkert,Ruth McPherson,Martin Farrall,Hugh Watkins,Eric S. Lander,James G. Wilson,Adolfo Correa,Eric Boerwinkle,Piera Angelica Merlini,Diego Ardissino,Danish Saleheen,Stacey Gabriel,Sekar Kathiresan,Sekar Kathiresan +39 more
Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment
Albert Wiegman,Samuel S. Gidding,Gerald F. Watts,M. John Chapman,Henry N. Ginsberg,Marina Cuchel,Leiv Ose,Maurizio Averna,Catherine Boileau,Jan Borén,Eric Bruckert,Alberico L. Catapano,Joep C. Defesche,Olivier S. Descamps,Robert A. Hegele,G. Kees Hovingh,Steve E. Humphries,Petri T. Kovanen,Jan Albert Kuivenhoven,Luis Masana,Børge G. Nordestgaard,Päivi Pajukanta,Klaus G. Parhofer,Frederick J. Raal,Kausik K. Ray,Raul D. Santos,Anton F. H. Stalenhoef,Elisabeth Steinhagen-Thiessen,Erik S.G. Stroes,Marja-Riitta Taskinen,Marja-Riitta Taskinen,Anne Tybjærg-Hansen,Olov Wiklund +32 more
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
Philippa J. Talmud,Sonia Shah,Ros Whittall,Marta Futema,Philip N. Howard,Jackie A. Cooper,Seamus C. Harrison,KaWah Li,Fotios Drenos,F Karpe,H. Andrew W. Neil,Olivier S. Descamps,Claudia Langenberg,Claudia Langenberg,Nicholas Lench,Mika Kivimäki,John C. Whittaker,John C. Whittaker,Aroon D. Hingorani,Meena Kumari,Steve E. Humphries +20 more